000518 *ST四环生物
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)-3.475-25.777-14.490-8.389-5.580
总资产报酬率 ROA (%)-2.359-17.909-10.760-6.347-4.287
投入资产回报率 ROIC (%)-2.963-22.132-12.951-7.593-5.180

边际利润分析
销售毛利率 (%)33.81062.68269.76171.03569.418
营业利润率 (%)-4.461-38.747-32.517-20.047-10.103
息税前利润/营业总收入 (%)-4.303-54.869-32.725-19.249-9.536
净利润/营业总收入 (%)-4.584-55.920-34.158-19.723-10.905

收益指标分析
经营活动净收益/利润总额(%)85.86933.03065.80676.61179.812
价值变动净收益/利润总额(%)-10.826-0.441-2.1750.4871.507
营业外收支净额/利润总额(%)6.72630.6653.618-1.0281.602

偿债能力分析
流动比率 (X)4.4483.3394.3114.8605.131
速动比率 (X)1.9570.6480.8541.3431.569
资产负债率 (%)24.28929.68422.42119.58919.083
带息债务/全部投入资本 (%)3.5139.5626.0375.2024.463
股东权益/带息债务 (%)2,506.436865.0561,464.9781,734.0842,034.423
股东权益/负债合计 (%)290.310220.694325.050385.412397.306
利息保障倍数 (X)-8.983-54.078-32.322-32.414-13.019

营运能力分析
应收账款周转天数 (天)64.367120.182129.931146.201130.011
存货周转天数 (天)403.3331,821.1282,066.5601,930.9871,475.480